If scorekeepers gave points for wit, this week would earn an honorable mention—showcasing the market’s ability to sprint, stumble, and get up again before anyone starts playing the national anthem. Investors, however, are left pondering what comes next, armed with quarterly reports,…
Modular Medical (NASDAQ: MODD) recently ramped up the news cycle with a flurry of regulatory milestones, engineering feats, and even a bit of C-suite global musical chairs—all tailored to make insulin delivery as easy as changing your socks (and almost as affordable).…
In a biotech climate where milestones arrive with the precision of a quarterly forecast and often carry as much suspense as a regulatory ruling, Eupraxia Pharmaceuticals (NASDAQ: EPRX) unveiled (after the close on Nov. 13) new 52-week follow-up data from its RESOLVE…
The opening bell rings as McDonald’s (MCD) steps onto the trading floor with the quiet confidence of a long-tenured heavyweight. This quarter isn’t a fireworks show; it’s a well-tuned engine: disciplined pricing, reliable traffic, and a franchise framework that stays resilient even…
Equities ended the session notably weaker after a volatile day characterized by renewed selling in tech and high-growth names. Major indices closed lower, with the Nasdaq Composite leading declines among the big three benchmarks. The day’s moves underscored a shift in risk…
A brisk wind swept through the newsroom, carrying whispers of relief, risk, and the soft clack of keyboards. Screens flashed tickers as traders recalibrated after the shutdown’s end, a concrete event that shifted sentiment more decisively than a surprise rate cut. The…
Waymo’s latest milestone—rolling driverless robotaxis onto U.S. freeways across select markets—reads like a sector earnings beat in real time. The move expands utilization horizons, tests risk-adjusted margins, and tightens the link between autonomous software reliability and fleet economics. Investors are watching how…
The major indices closed with a mixed tone after a session of careful balance between safety in value plays and the still-ambitious tilt toward growth. The S&P 500 eked out a gain, the Dow inched into positive territory as fresh macro cues…
Centessa Pharmaceuticals made waves in biotech finance this week by pricing its $250 million public offering at $21.50 per American Depositary Share (ADS)—a move that sent investors and industry watchers scrambling for their calculators and a fresh cup of clinical optimism.
Raising…
Advanced Micro Devices (AMD) is setting the stage for a robust resurgence in the data center arena, projecting a 60% jump in revenue over the next three to five years. This forecast, unveiled at the company's recent Financial Analyst Day, underscores AMD's…
